AGHEMO, ALESSIO MICHELE

AGHEMO, ALESSIO MICHELE  

Universita' degli Studi di MILANO  

Mostra records
Risultati 1 - 20 di 139 (tempo di esecuzione: 0.0 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
A morphometric and immunohistochemical study to assess the benefit of an svr in hcv cirrhotic patients 1-ago-2012 R. D'AmbrosioA. AghemoM. RumiM. Colombo + Article (author) -
Acute tubular necrosis following interferon-based therapy for hepatitis C : case study with literature review 1-gen-2014 A. AghemoR. D'AmbrosioP. Messa + Article (author) -
Allelic inhibition of displacement activity : a simplified one tube allele-specific PCR for evaluation of ITPA polymorphisms 1-feb-2013 E. GalmozziF. FacchettiE. DegasperiA. AghemoP. Lampertico Article (author) -
An a priori prediction model of response to peginterferon plus ribavirin dual therapy in naïve patients with genotype 1 chronic hepatitis C 1-gen-2014 A. AghemoE. Grassi + Article (author) -
Anemia during peginterferon-ribavirin therapy results from both increased suppression of erythroid differentiation and haemolysis 1-gen-2008 A. AghemoL. RonzoniM. RumiS. MonicoP. GrilloM. ViganòM.D. CappelliniM. Colombo + Article (author) -
Anti-TNF drugs in patients with hepatitis B or C virus infection : safety and clinical management 1-feb-2012 E. DegasperiA. AghemoP. LamperticoM. Colombo + Article (author) -
Assessing long-term treatment efficacy in chronic hepatitis B and C : Between evidence and common sense 1-dic-2012 A. AghemoP. LamperticoM. Colombo Article (author) -
Assessing safety and efficacy of sofosbuvir for the treatment of hepatitis C 1-gen-2015 R. D'AmbrosioA. AghemoM. Colombo Article (author) -
Bridging all oral DAA therapy from wait time to post-liver transplant to improve HCV eradication? 1-gen-2015 S. MonicoF. MalinvernoA. AghemoM. Colombo + Article (author) -
Challenges in treating patients with inflammatory bowel disease and concurrent viral hepatitis infection 1-dic-2016 DEGASPERI, ELISABETTAF. CaprioliM. ColomboA. Aghemo + Article (author) -
Cirrhosis and rapid virological response to peginterferon plus ribavirin determine treatment outcome in HCV-1 IL28B rs12979860 CC patients 9-lug-2013 A. AghemoE. DegasperiM.G. RumiE. GalmozziL. ValentiR. De FrancescoS. De NicolaC. CheroniM. Colombo + Article (author) -
Clinical significance of residual viremia detected by two real-time PCR assays for response-guided therapy of HCV genotype 1 infection 1-gen-2014 A. AghemoM. Colombo + Article (author) -
Commentary : Absolute and relative contraindications to pegylated-interferon or ribavirin in the US general patient population with chronic hepatitis C 1-gen-2013 A. AghemoP. Lampertico Article (author) -
Comparative trials of peginterferon α2a and peginterferon α2b for chronic hepatitis C 1-gen-2012 M. RumiA.M. AghemoG.M. Prati Article (author) -
Comparison of three therapeutic regimens for genotype-3 hepatitis C virus infection in a large real-life multicentre cohort 1-apr-2020 Lapadula G.Valsecchi M. G.Carriero C.Degasperi E.Pasulo L.Baiguera C.Menzaghi B.Lombardi A.Aghemo A.Rumi M. G.Valenti L.De Bona A.d'Arminio Monforte A.Bonfanti P.Perini P.Capretti A.Ciaccio A.Lampertico P. + Article (author) -
Contrast-enhanced computed tomography and ultrasound-guided liver biopsy to diagnose dysplastic liver nodules in cirrhosis 1-gen-2013 M. IavaroneM.A. ManiniL. Di TommasoA. AghemoM. RoncalliM. Colombo + Article (author) -
COVID-19 and liver disease 1-giu-2020 Aghemo A.Valenti L. + Article (author) -
COVID-19 and the liver: A 2021 update 1-set-2021 Aghemo A.Valenti L. + Article (author) -
Daclatasvir : a team player rather than a prima donna in the treatment of hepatitis C 1-giu-2015 A. AghemoR. De Francesco Article (author) -
Daclatasvir for the treatment of chronic hepatitis C 1-gen-2015 E. DegasperiA. AghemoM. Colombo Article (author) -